Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Radiomic and clinical predictors of epidermal growth factor receptor mutation in stage IA non-small cell lung cancer.

PeerJ - 1 Jan 2026

Guan Wanxian, Chen Jiaqing, Zeng Xueqing, Chen Yulan, Liu Baoyi, Xin Pengaolong, Huang Zhizhen, Chen Woqing, Zheng Yan, Chen Jiarong, Ren Liangliang, Ren Dong, Zhang Xin, Huang Yanming, Liu Shengming

Abstract excerpt

Background: Epidermal growth factor receptor (EGFR) mutation status plays a critical role in guiding targeted therapy for non-small cell lung cancer (NSCLC). However, molecular testing in patients with stage IA NSCLC may be limited by insufficient tissue availability, procedural invasiveness, and resource constraints. Therefore, developing a non-invasive approach for EGFR mutation prediction is of substantial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Machine Learning

Share to Neoplasm Staging

Share to Radiomics

Share to Tomography, X-Ray Computed

Source

Open in PubMed Open full text

Identifiers

PMID: 42564746
DOI: 10.7717/peerj.21579
PMCID: PMC13446228

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Radiomic and clinical predictors of epidermal growth factor receptor mutation in stage IA non-small cell lung cancer.PMID 42564746Read ↗

The Potential of Radiomics Nomogram in Non-invasively Prediction of Epidermal Growth Factor Receptor Mutation Status and Subtypes in Lung AdenocarcinomaSemantic proximity Read ↗

Detailed identification of epidermal growth factor receptor mutations in lung adenocarcinoma: Combining radiomics with machine learning.Semantic proximity Read ↗

Accurate prediction of epidermal growth factor receptor mutation status in early-stage lung adenocarcinoma, using radiomics and clinical features.Semantic proximity Read ↗

Prediction of EGFR mutation status in non-small cell lung cancer based on multiparametric MRI radiomics.Semantic proximity Read ↗

Integrated CT-derived radiomics for predicting ctDNA status and prognosis in resectable non-small cell lung cancerSemantic proximity Read ↗

A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.Semantic proximity Read ↗

Using CT image-based radiomics to predict EGFR mutations in lung adenocarcinomaSemantic proximity Read ↗

CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer.Semantic proximity Read ↗

Machine Learning-Based Radiomics Signatures for EGFR and KRAS Mutations Prediction in Non-Small-Cell Lung Cancer.Semantic proximity Read ↗

Machine Learning-Based Radiomics for Prediction of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma.Semantic proximity Read ↗

Deep learning-radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients.Semantic proximity Read ↗

The Predictive Value of 18F-FDG PET/CT Radiomics in EGFR Gene Mutation of Lung Adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.